The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
Open accessAbstract
Human-derived neurons provide the answers: Pathways involved in energy metabolism and removal of cellular debris by lysosomes play an important role in protecting our brain from degeneration in Parkinson's disease. Burbulla et al. identified a toxic cascade of mitochondrial and lysosomal dysfunction in human neurons derived from patients with Parkinson's. The dysfunction was mediated by accumulation of oxidized dopamine and α-synuclein, but it was not found in Parkinson's mouse models, owing to species-specific differences in dopamine metabolism. Inherent species-specific differences between human and mouse neurons emphasize the value of studying human neurons to identify relevant targets for treatment of Parkinson's disease and related synucleinopathies. Science , this issue p. 1255
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“dopaminergic neurons, which are selectively vulnerable in Parkinson’s Disease, contain substantially higher levels of dopamine in humans compared to mice, and some cellular disease processes have been proposed to depend on the high levels of dopamine found only in human dopaminergic neurons18.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [18]
In the citing paper
“First, there are differences between disease-relevant cell types, such as neurons and glia, between humans and mice.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [18]
In the citing paper
“iPSC-derived dopaminergic neurons recapitulate molecular processes characteristic of Parkinson’s Disease, dependent on dopamine levels18.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [18]
In the citing paper
“DAQ has been found in human induced pluripotent stem cell-derived dopaminergic neurons that carry mutations associated with PD269.”
From Rhythms of life: circadian disruption and brain disorders across the lifespan (2019) · cites this paper as [269]
In the citing paper
“This study demonstrates that mitochondrial stress promotes the accumulation of oxidized dopamine, consequently increasing α-synuclein aggregates in neurons derived from patients with PD, an effect selective to human neurons.”
From Rhythms of life: circadian disruption and brain disorders across the lifespan (2019) · cites this paper as [269]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Elias, J. E., & Gygi, S. P. (2007) · Nature Methods · doi:10.1038/nmeth1019 · Cited by 3,925
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854
The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127
Kriks, S., Shim, J., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo‐Reid, L., Auyeung, G., Antonacci, C. L., Buch, A., et al. (2011) · Nature · doi:10.1038/nature10648 · Cited by 1,951
Self-citationMazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341
Self-citationEfficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells
Lee, S., Lumelsky, N. L., Studer, L., Auerbach, J. M., & McKay, R. D. G. (2000) · Nature Biotechnology · doi:10.1038/76536 · Cited by 1,261
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Self-citationα-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Wong, Y. C., & Krainc, D. (2017) · Nature Medicine · doi:10.1038/nm.4269 · Cited by 897
Self-citationGenetic Animal Models of Parkinson's Disease
Dawson, T. M., Ko, H. S., & Dawson, V. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.034 · Cited by 866
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Guzmán, J. N., Sánchez-Padilla, J., Wokosin, D. L., Kondapalli, J., Ilijić, E., Schumacker, P. T., & Surmeier, D. J. (2010) · Nature · doi:10.1038/nature09536 · Cited by 864
Self-citationHuman iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
Self-citationMosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., & Sulzer, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.033 · Cited by 548
Lin, X. Z., Parisiadou, L., Gu, X., Wang, L., Shim, H., Sun, L., Xie, C., Long, C.-X., Yang, W.-J., Ding, J., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.006 · Cited by 532
Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003985 · Cited by 508
Self-citationOxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases
Choi, J., Sullards, M. C., Olzmann, J. A., Rees, H. D., Weintraub, S. T., Bostwick, D. E., Gearing, M., Levey, A. I., Chin, L., & Li, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509079200 · Cited by 489
Sulzer, D. L., Bogulavsky, J. J., Larsen, K. E., Behr, G. G., Karatekin, E., Kleinman, M. H., Turro, N. J., Krantz, D. E., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 460
Robust Pacemaking in Substantia Nigra Dopaminergic Neurons
Guzmán, J. N., Sánchez-Padilla, J., Chan, C. S., & Surmeier, D. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2519-09.2009 · Cited by 405
Self-citationMazzulli, J. R., Zunke, F., Ole Isacson, A., Studer, L., & Krainc, D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520335113 · Cited by 398
Self-citationSeibler, P., Graziotto, J. J., Jeong, H., Šimunović, F., Klein, C., & Krainc, D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4441-10.2011 · Cited by 388
Self-citationKrebiehl, G., Ruckerbauer, S., Burbulla, L. F., Kieper, N., Maurer, B., Waak, J., Wolburg, H., Gizatullina, Z. Z., Gellerich, F. N., Woitalla, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009367 · Cited by 381
Self-citationNovel antibodies to synuclein show abundant striatal pathology in Lewy body diseases
Duda, J. E., Giasson, B. I., Mabon, M. E., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · Annals of Neurology · doi:10.1002/ana.10279 · Cited by 322
Mazzulli, J. R., Zunke, F., Tsunemi, T., Toker, N., Jeon, S., Burbulla, L. F., Patnaik, S., Sidransky, E., Marugán, J., Sue, C. M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0628-16.2016 · Cited by 281
Self-citationAge-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice
Chen, L., Cagniard, B., Mathews, T. A., Jones, S. R., Koh, H. C., Ding, Y., Carvey, P. M., Ling, Z., Kang, U. J., & Zhuang, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413955200 · Cited by 268
Self-citationZecca, L., Bellei, C., Costi, P., Albertini, A., Monzani, E., Casella, L., Gallorini, M., Bergamaschi, L., Moscatelli, A., Turro, N. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808768105 · Cited by 240
Dryanovski, D. I., Guzmán, J. N., Xie, Z., Galteri, D. J., Volpicelli‐Daley, L. A., Lee, V. M. Y., Miller, R. J., Schumacker, P. T., & Surmeier, D. J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5311-12.2013 · Cited by 215
Self-citationChen, L., Xie, Z., Turkson, S., & Zhuang, X. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0089-14.2015 · Cited by 194
Self-citationChapter 19 Methods to Monitor Chaperone‐Mediated Autophagy
Kaushik, S., & Cuervo, A. M. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)03619-7 · Cited by 134
DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology
Taipa, R. J. F., Pereira, C., Reis, I., Alonso, I. D. C. M. P., Lima, A. B., Pires, M. M., & Magalhães, M. (2016) · Brain · doi:10.1093/brain/aww080 · Cited by 131
Calcineurin determines toxic versus beneficial responses to α-synuclein
Caraveo, G., Auluck, P. K., Whitesell, L. J., Chung, C. Y., Baru, V., Mosharov, E. V., Yan, X., Johny, M. B., Soste, M., Picotti, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413201111 · Cited by 127
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
Hering, R., Strauss, K. M., Tao, X., Bauer, A., Woitalla, D., Mietz, E.-M., Petrovic, S., Bauer, P., Schaible, W., Müller, T. H., et al. (2004) · Human Mutation · doi:10.1002/humu.20089 · Cited by 123
Self-citationParkinson Study Group (2013) · Movement Disorders · doi:10.1002/mds.25639 · Cited by 113
Mitochondrial dysfunction associated with glucocerebrosidase deficiency
Gegg, M. E., & Schapira, A. H. V. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.09.006 · Cited by 97
Plum, S., Steinbach, S., Attems, J., Keers, S. M., Riederer, P. F., Gerlach, M., May, C., & Marcus, K. (2016) · Scientific Reports · doi:10.1038/srep37139 · Cited by 47
Detection of Free and Protein-Bound ortho -Quinones by Near-Infrared Fluorescence
Mazzulli, J. R., Burbulla, L. F., Krainc, D., & Ischiropoulos, H. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04420 · Cited by 34
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Bloem, B. R., Okun, M. S., & Klein, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00218-x · Cited by 3,920
13 reasons why the brain is susceptible to oxidative stress
Cobley, J. N., Fiorello, M. L., & Bailey, D. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.008 · Cited by 1,215
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Self-citationMitochondria–lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis
Wong, Y. C., Ysselstein, D., & Krainc, D. (2018) · Nature · doi:10.1038/nature25486 · Cited by 911
Self-citationCalabresi, P., Mechelli, A., Natale, G., Volpicelli‐Daley, L. A., Lazzaro, G. D., & Ghiglieri, V. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05672-9 · Cited by 930
Metadata
- Authors
- Burbulla, L. F., Song, P., Mazzulli, J. R., Zampese, E., Wong, Y. C., Jeon, S., Santos, D. P., Blanz, J., Obermaier, C. D., Strojny, C., Savas, J. N., Kiskinis, E., Zhuang, X., Krüger, R., Surmeier, D. J., & Krainc, D.
- Affiliations
- Northwestern University (US)
- University of Luxembourg (LU)
- University of Chicago (US)
- Centre Hospitalier de Luxembourg (LU)
- Corresponding author
- Krainc, Dimitri
- ORCID
- Venue
- Science
- Published
- 2017-09-22
- Volume
- 357
- Issue
- 6357
- Pages
- 1255-1261
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6021018
- OpenAlex
- W2752710053
- Cited by
- 874
- References
- 37
- Citations by year
- 2026: 83 · 2025: 99 · 2024: 110 · 2023: 93 · 2022: 100 · 2021: 98 · 2020: 108 · 2019: 91 · 2018: 76 · 2017: 16
- FWCI
- 54.93
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- NIH Office of the Director (award301003, R01NS076054, award301024, R00DC013805-02, award346646, T32NS041234, award346647, F32NS101778, award346648, R01NS092823)
- IDP Foundation (award346545)
- Michael J. Fox Foundation for Parkinson’s Research (award346546)
- JPB Foundation (award346543)
- NIH (award346544, NS047085)
- German Academic Exchange Service (award301004)
- Spinal Muscular Atrophy Foundation (award301007)
- Les Turner ALS Foundation (award301005)
- Target ALS (award301006)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, dopamine oxidation, mitochondrial dysfunction, lysosomal dysfunction, dopaminergic neurons, substantia nigra, glucocerebrosidase, alpha-synuclein, oxidative stress, familial Parkinson's disease, neurodegeneration
- MeSH terms
- Protein Deglycase DJ-1, Animals, Antioxidants, Cell Line, Disease Models, Animal, Dopamine, Glucosylceramidase, Humans, Lysosomes, Melanins, Mesencephalon, Mitochondria, Oxidation-Reduction, Parkinson Disease, Substantia Nigra, Tacrolimus, Mice, Knockout, Oxidative Stress, Mice, alpha-Synuclein, Dopaminergic Neurons, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
